Endo reaffirmed earnings guidance for the third quarter of 2016. For the quarter, the company expects revenue between $830 million and $870 million and adjusted EPS between $0.77 and $0.82, while also confirming the Fiscal Year guidance of revenue between $3.87 billion and $4.03 billion with EPS of $4.50 to $4.80.